Stock listing
NASDAQ:RXRX Recursion Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Recursion Pharmaceuticals, Inc.
Follow Recursion Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RXRX
$3.83 USD -0.20 (-5.0%)
Close on Nov 2, 2026
- Day range
- $3.78 – $4.17 USDNov 2, 2026
- Volume
- 22.44M sharesNov 2, 2026
- Market cap
- $2.29B USDAt the close on Nov 2, 2026 · price × 596.9M shares outstanding
- 52-week range
- $2.77 – $5.76 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $84.49M USDMedian day 18.84M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RXRX · Home | $3.83 USD | -0.20 (-5.0%) | 22,444,255 | $4.125 | $4.17 | $3.78 | $4.03 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:RXRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.83 | -0.20 | -5.0% | $4.125 | $4.17 | $3.78 | 22,444,255 | |
| $4.03 | -0.21 | -5.0% | $4.05 | $4.16 | $3.785 | 24,357,781 | |
| $4.24 | -0.11 | -2.5% | $4.24 | $4.515 | $4.15 | 20,566,825 | |
| $4.35 | +0.30 | +7.4% | $4.00 | $4.43 | $3.995 | 28,353,942 | |
| $4.05 | +0.25 | +6.6% | $3.81 | $4.145 | $3.73 | 22,100,545 | |
| $3.80 | +0.10 | +2.7% | $3.72 | $3.86 | $3.64 | 16,055,282 | |
| $3.70 | +0.12 | +3.4% | $3.52 | $3.70 | $3.45 | 19,038,600 | |
| $3.58 | -0.06 | -1.6% | $3.54 | $3.68 | $3.485 | 17,735,700 | |
| $3.64 | -0.02 | -0.5% | $3.66 | $3.76 | $3.56 | 19,356,500 | |
| $3.66 | +0.05 | +1.4% | $3.555 | $3.67 | $3.47 | 20,925,100 | |
| $3.61 | +0.145 | +4.2% | $3.53 | $3.69 | $3.48 | 30,009,600 | |
| $3.465 | -0.695 | -16.7% | $4.11 | $4.185 | $3.44 | 40,724,300 | |
| $4.16 | +0.42 | +11.2% | $3.65 | $4.41 | $3.53 | 62,870,100 | |
| $3.74 | -0.095 | -2.5% | $3.72 | $3.91 | $3.66 | 18,783,700 | |
| $3.835 | -0.175 | -4.4% | $4.01 | $4.05 | $3.82 | 19,764,300 | |
| $4.01 | -0.35 | -8.0% | $4.31 | $4.365 | $3.91 | 23,785,300 | |
| $4.36 | +0.41 | +10.4% | $4.015 | $4.43 | $3.89 | 35,501,300 | |
| $3.95 | -0.32 | -7.5% | $4.19 | $4.20 | $3.79 | 30,898,400 | |
| $4.27 | -0.36 | -7.8% | $4.505 | $4.60 | $4.23 | 40,730,500 | |
| $4.63 | -0.15 | -3.1% | $4.81 | $5.19 | $4.395 | 71,106,000 | |
| $4.78 | +0.66 | +16.0% | $4.16 | $4.935 | $4.06 | 67,278,700 | |
| $4.12 | +0.05 | +1.2% | $4.18 | $4.27 | $4.01 | 18,840,000 | |
| $4.07 | -0.06 | -1.5% | $4.07 | $4.17 | $3.96 | 17,484,100 | |
| $4.13 | +0.10 | +2.5% | $4.09 | $4.29 | $3.98 | 32,785,900 | |
| $4.03 | +0.33 | +8.9% | $3.73 | $4.04 | $3.723 | 21,564,000 | |
| $3.70 | -0.04 | -1.1% | $3.69 | $3.84 | $3.665 | 13,058,800 | |
| $3.74 | -0.15 | -3.9% | $3.89 | $3.90 | $3.70 | 10,481,300 | |
| $3.89 | +0.19 | +5.1% | $3.65 | $3.90 | $3.61 | 19,338,300 | |
| $3.70 | -0.35 | -8.6% | $4.03 | $4.09 | $3.66 | 23,670,600 | |
| $4.05 | +0.08 | +2.0% | $4.00 | $4.16 | $3.90 | 40,460,400 | |
| $3.97 | +0.14 | +3.7% | $3.92 | $4.015 | $3.83 | 37,728,700 | |
| $3.83 | +0.29 | +8.2% | $3.54 | $3.83 | $3.50 | 44,325,600 | |
| $3.54 | +0.35 | +11.0% | $3.28 | $3.59 | $3.26 | 28,251,200 | |
| $3.19 | -0.05 | -1.5% | $3.26 | $3.31 | $3.16 | 14,813,900 | |
| $3.24 | -0.17 | -5.0% | $3.37 | $3.37 | $3.22 | 11,881,300 | |
| $3.41 | +0.21 | +6.6% | $3.19 | $3.455 | $3.18 | 17,102,500 | |
| $3.20 | +0.04 | +1.3% | $3.21 | $3.25 | $3.15 | 8,034,100 | |
| $3.16 | -0.055 | -1.7% | $3.14 | $3.25 | $3.10 | 10,617,000 | |
| $3.215 | -0.225 | -6.5% | $3.42 | $3.45 | $3.21 | 14,198,900 | |
| $3.44 | -0.19 | -5.2% | $3.58 | $3.59 | $3.43 | 14,990,200 | |
| $3.63 | +0.19 | +5.5% | $3.415 | $3.70 | $3.41 | 29,039,100 | |
| $3.44 | +0.06 | +1.8% | $3.435 | $3.45 | $3.29 | 13,746,100 | |
| $3.38 | +0.05 | +1.5% | $3.34 | $3.489 | $3.285 | 14,052,700 | |
| $3.33 | -0.07 | -2.1% | $3.34 | $3.38 | $3.28 | 9,991,900 | |
| $3.40 | +0.06 | +1.8% | $3.305 | $3.41 | $3.25 | 13,903,400 | |
| $3.34 | -0.10 | -2.9% | $3.40 | $3.45 | $3.31 | 10,560,600 | |
| $3.44 | -0.05 | -1.4% | $3.515 | $3.55 | $3.42 | 10,986,800 | |
| $3.49 | -0.07 | -2.0% | $3.51 | $3.55 | $3.43 | 12,978,400 | |
| $3.56 | +0.31 | +9.5% | $3.27 | $3.59 | $3.26 | 22,516,700 | |
| $3.25 | -0.25 | -7.1% | $3.42 | $3.44 | $3.215 | 15,155,100 | |
| $3.50 | +0.16 | +4.8% | $3.39 | $3.63 | $3.37 | 22,898,500 | |
| $3.34 | -0.16 | -4.6% | $3.40 | $3.46 | $3.27 | 21,453,700 | |
| $3.50 | +0.41 | +13.3% | $3.275 | $3.50 | $3.19 | 30,369,700 | |
| $3.09 | -0.02 | -0.6% | $3.03 | $3.10 | $2.92 | 16,348,300 | |
| $3.11 | -0.05 | -1.6% | $3.12 | $3.16 | $3.08 | 10,621,600 | |
| $3.16 | -0.15 | -4.5% | $3.30 | $3.305 | $3.14 | 10,545,200 | |
| $3.31 | +0.02 | +0.6% | $3.31 | $3.35 | $3.27 | 10,700,000 | |
| $3.29 | -0.06 | -1.8% | $3.37 | $3.38 | $3.26 | 10,305,100 | |
| $3.35 | +0.06 | +1.8% | $3.32 | $3.42 | $3.27 | 11,008,300 | |
| $3.29 | +0.07 | +2.2% | $3.20 | $3.36 | $3.19 | 14,034,800 | |
| $3.22 | +0.04 | +1.3% | $3.254 | $3.265 | $3.18 | 9,355,900 | |
| $3.18 | +0.01 | +0.3% | $3.13 | $3.26 | $3.115 | 14,794,400 | |
| $3.17 | -0.14 | -4.2% | $3.08 | $3.23 | $3.01 | 17,458,800 | |
| $3.31 | +0.13 | +4.1% | $3.265 | $3.36 | $3.21 | 21,577,800 | |
| $3.18 | +0.18 | +6.0% | $3.03 | $3.20 | $3.00 | 14,721,800 |
- Ticker
- NASDAQ:RXRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
Latest earnings call · Aug 5, 2026
Recursion Pharmaceuticals (NASDAQ:RXRX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 44 slides
Calls
Upcoming
Recursion Pharmaceuticals (NASDAQ:RXRX) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Register
Replays
Recursion Pharmaceuticals (NASDAQ:RXRX) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 8:00 AM ET
Watch TranscriptRecursion Pharmaceuticals (NASDAQ:RXRX) Q1 2026 Earnings Call
Wed, May 06, 2026 · 8:00 AM ET
Watch TranscriptRecursion Pharmaceuticals (NASDAQ:RXRX) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
Oct 26, 2026
Closed $4.05 (+6.6%) on Oct 27, 2026
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
Oct 15, 2026
Closed $4.16 (+11.2%) on Oct 15, 2026
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
Oct 15, 2026
Closed $4.16 (+11.2%) on Oct 15, 2026
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
Oct 15, 2026
Closed $4.16 (+11.2%) on Oct 15, 2026
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Aug 5, 2026
Closed $3.17 (-4.2%) on Aug 5, 2026
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
Jul 29, 2026
Closed $2.97 (-2.6%) on Jul 29, 2026
Remix Therapeutics to Present at AACR Drug Discovery and Development Conference
Jul 16, 2026
Closed $3.02 (-8.8%) on Jul 16, 2026
Recursion Reports First Quarter Financial Results and Provides Business Update
May 6, 2026
Closed $3.43 (+1.8%) on May 6, 2026
Financings
Public offering of class A common stock
Oct 15, 2026
Announced: about US$200M · US$3.25 a share · Leerink Partners +4
Dealers: Leerink Partners (co-lead), Goldman Sachs & Co. LLC (co-lead), Morgan Stanley & Co. LLC (co-lead), Evercore Group L.L.C. (co-lead), Needham & Company, LLC
Buyers: Janus Henderson Investors; Invus; Longaeva Partners; ARK Invest; Driehaus Capital Management
Use of proceeds: Advance highest-conviction programs and deliver on upcoming clinical milestones
Decks
Investor Presentation (October 2026)
Investor deck · 44 slides · Oct 15, 2026
Corporate Update (August 2026)
Corporate update · 66 slides · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 38 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 34 slides · May 6, 2026
Recursion Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 121 in all · newest Nov 2, 2026 · oldest 2021
- Calls
- 9 calls with a replay · 9 with a transcript · latest Aug 5, 2026
- Decks
- 47 decks · latest Oct 15, 2026
Where Recursion Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RXRX · Home listing · This page | NASDAQ | United States | USD |
| BMV:RXRX | BMV | Mexico | MXN |
| BOATS:RXRX | BOATS | United States | USD |
| gettex:A3CM1C | gettex | Germany | EUR |
| BIVA:RXRX | BIVA | Mexico | MXN |
| BX Swiss:RXRX | BX Swiss | Switzerland | CHF |
| Stuttgart:8RL | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Recursion Pharmaceuticals, Inc.